LifeArc monetises Keytruda royalty interests to fund further research and investment

Private healthcare prices becoming more transparent but further progress needed, warns PHIN

New information on private healthcare prices published by the Private Healthcare Information Network (PHIN) will help patients to compare medical fees before seeking treatment,...
Political attitudes to prevention in the NHS

Political attitudes to prevention in the NHS

A new report from WA Health, Prevention over cure: political attitudes to prevention in the NHS Long Term Plan, informed by a cross-party YouGov poll...
Syringe with liquid to show new opportunities to increase adult vaccination rates

Technology opens new opportunities to increase adult vaccination rates

Technology opens new opportunities to increase adult vaccination rates and play a major role in overcoming some of the barriers to the uptake of...
BMA responds to RCGP's proposal of 15-minute GP appointments as standard

New NICE guidelines on referring patients with neurological conditions

New NICE guideline will help doctors recognise and refer people with suspected neurological conditions NICE has published its guideline on recognising and referring people with...
Ipad and the cloud: Further roll out of digital health hub

Further roll out of digital health hub across England

A digital health hub piloted in Nailsea is being scaled up across England, as demand increases from councils in North West London, the Wirral,...
Liz Cross: Addressing antimicrobial resistance

Addressing antimicrobial resistance

Liz Cross, advanced nurse practitioner and non-medical prescriber, is taking huge steps in reducing the unnecessary prescribing of antibiotics to address antimicrobial resistance (AMR). What is your...

Lack of public awareness in choice of hospitals when accessing NHS treatment

A new poll by Populus has identified a lack of public awareness in choice of hospitals when accessing NHS treatment. Populus interviewed 6116 adults online...
link between Type 2 diabetes and cardiovascular disease risk

New research into the link between Type 2 diabetes and cardiovascular disease risk

New research into the link between Type 2 diabetes and cardiovascular disease risk highlights improvements in cardiovascular risk for women developing Type 2 diabetes...

The role of clinical pharmacists in primary and community care

The General Practitioners Committee of the British Medical Association’s longstanding ambition for every GP practice to benefit from having a pharmacist is now much...
Digital experts to join cancer and mental health teams

NHSX: digital experts to join cancer and mental health teams

Digital experts to join cancer and mental health teams as part of the growth of NHSX - a new joint organisation for digital, data...

Latest articles

NICE to work with GW Pharma on cannabidiol evaluation

NICE to work with GW Pharma on cannabidiol evaluation

NICE has announced its intention to work with GW Pharma to address the issues highlighted by its independent appraisal committee in its evaluation of...
NHS Spine marks five years of being run as an open source service

NHS Spine marks five-year anniversary

NHS Spine is marking five years since it was brought in house by NHS Digital and run as an open source service for the...
robot holding chess piece: Cyber threats in healthcare

Cyber threats in healthcare: What are the risks?

FireEye have released a new report detailing cyber threats facing the healthcare industry. The report focuses on the three types of threat most common in...

Popular articles

Positive results for long acting injectable HIV treatment regimen

Positive phase III study results for injectable HIV-treatment regimen

ViiV Healthcare has announced positive headline results from its global phase III ATLAS-2M study of the investigational, long-acting, injectable, 2-drug regimen (2DR) of ViiV...
Gedeon Richter's biosimilar for osteoporosis available on NHS

Gedeon Richter’s biosimilar for osteoporosis available on NHS

Gedeon Richter has announced that its biosimilar for osteoporosis, Terrosa® (teriparatide), is available on the NHS for the treatment of osteoporosis in postmenopausal women...
robot holding chess piece: Cyber threats in healthcare

Cyber threats in healthcare: What are the risks?

FireEye have released a new report detailing cyber threats facing the healthcare industry. The report focuses on the three types of threat most common in...
Roche's Hemlibra® available on NHS

NHS England makes Roche’s Hemlibra® available on NHS

NHS England has made Roche's Hemlibra® available on NHS. It is to fund the “life-changing treatment” for thousands of people with severe Haemophilia, which...
NICE to work with GW Pharma on cannabidiol evaluation

NICE to work with GW Pharma on cannabidiol evaluation

NICE has announced its intention to work with GW Pharma to address the issues highlighted by its independent appraisal committee in its evaluation of...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription